Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05197920 · ClinicalTrials.gov registry record

Diabetes RElated to Acute Pancreatitis and Its Mechanisms

A clinical trial of Acute Pancreatitis, sponsored by Milton S. Hershey Medical Center.

Recruiting
Registry status
800
Enrollment target
13
Study locations

NCT05197920 is a study of Acute Pancreatitis that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 800 participants, below the 2,239-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (64% lower). The trial reports 13 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05197920, a study of Acute Pancreatitis, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.

RECRUITING
Registry status
800 participants
Enrollment target
13
Study locations

Study Summary

The overriding objective of DREAM is to conduct a prospective longitudinal (36 months) observational clinical study to investigate the incidence, etiology, and pathophysiology of diabetes mellitus (DM) following acute pancreatitis (AP).

Conditions Studied

Study Locations (13)

California

  • University of Southern California - Los Angeles
  • Cedars-Sinai Medical Center - Los Angeles
  • Stanford University - Stanford

Florida

  • University of Florida - Gainesville
  • AdventHealth - Orlando

Illinois

  • Northwestern University - Chicago
  • University of Illinois at Chicago - Chicago

Indiana

  • Indiana University - Indianapolis

Maryland

  • Johns Hopkins University - Baltimore

Minnesota

  • University of Minnesota - Minneapolis

Ohio

  • Ohio State University - Columbus

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2022-01-14
Est. Completion 2030-01-31

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT05197920

The ClinicalTrials.gov registry entry for NCT05197920 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,239-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (64% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Pancreatitis appearing as the primary indexed condition, and to 0 interventions.

NCT05197920 reports 13 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT05197920 about?

NCT05197920 is a clinical study titled "Diabetes RElated to Acute Pancreatitis and Its Mechanisms". The overriding objective of DREAM is to conduct a prospective longitudinal (36 months) observational clinical study to investigate the incidence, etiology, and pathophysiology of diabetes mellitus (DM) following acute pancreatitis (AP).

What is the current status of trial NCT05197920?

This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2022-01-14. Estimated completion is 2030-01-31.

What conditions does trial NCT05197920 study?

This clinical trial studies the following conditions: Acute Pancreatitis.

Who is sponsoring clinical trial NCT05197920?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05197920 being conducted?

This trial has 13 study locations across California, Florida, Illinois, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Pancreatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.